4//SEC Filing
McLaughlin Matthew T E 4
Accession 0001437749-20-005160
CIK 0001586049other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:33 PM ET
Size
6.6 KB
Accession
0001437749-20-005160
Insider Transaction Report
Form 4
McLaughlin Matthew T E
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2020-03-11+34,795→ 34,795 totalExercise: $12.19Exp: 2030-03-11→ Ordinary Shares (34,795 underlying) - Award
Ordinary Shares
2020-03-11+34,795→ 61,407 total
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2021 through January 1, 2024.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001773442
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:33 PM ET
- Size
- 6.6 KB